Fraxel Before and After: What Results Look Like

Fraxel's current model is the Fraxel FTX (Solta Medical), cleared through the FDA's 510(k) pathway on 21 Aug 2024 (K242142) — cleared, not FDA-approved.

It carries two wavelengths, 1550 nm and 1927 nm.

The earlier Fraxel DUAL 1550/1927, cleared on 14 Jun 2013 (K130193), carried the same pair, so a photo captioned "Fraxel Dual" names the earlier cleared model of the same two wavelengths.

Solta is part of Bausch Health Companies Inc., whose trademarks include the Fraxel brand.

What a "result" means here comes from the uses Solta lists for those wavelengths, and the lists split: the 1550 nm wavelength is listed for skin resurfacing including dyschromia (uneven pigment), age and sun spots, actinic keratosis — Solta's text calls these pre-cancerous skin lesions — melasma, wrinkles around the eyes, and acne and surgical scars, while the 1927 nm wavelength is listed for resurfacing including actinic keratosis and pigmented lesions such as age spots, sun spots and freckles.

The only visibility statement in our research is Solta's own: results may show after one treatment, though up to five may be appropriate.

Beyond that, our research holds no photographed Fraxel trial and no percentage-improvement figure for any concern, so this page quotes no typical outcome — and no gallery should promise one.

Our Fraxel guide covers the device itself, the downtime and who it suits.

Solta's own answer is a range, and its wording is worth keeping whole: "Depending upon individual needs and treatment goals, up to five treatments may be appropriate, although fewer treatments may be suitable for some patients." The honest session count is set per person, not by a menu.

Per Solta, a full-face session takes 20 to 25 minutes after about 60 minutes of topical numbing.

Two timing notes before you judge any before-and-after, a provider's or your own.

First, the early days understate the result: Solta's recovery timeline describes itching, flaking and visible laser "dots" or darkening on days 1–2, peeling on days 3–4 for the face, and redness resolved by about day 15 in its example patient — one patient, not an average.

Second, the result is maintained rather than finished: Solta advises SPF 30+ and avoiding direct sun for at least 3 months after the last treatment.

Session count is a main price driver, too; our Fraxel cost page covers pricing.

Beyond Solta's range, we found no sourced rule that maps a session count to a specific concern — that is a question for the provider who examines your skin.

Solta splits its stated uses between the two wavelengths, so the concern in your own before-and-after decides which wavelength a provider would use.

The list is Solta's, not a set of promised outcomes.

Melasma. Melasma appears only on the 1550 nm side of the list, and the published evidence is more cautious than a gallery caption: a 2020 evidence review (McKesey, Tovar-Garza and Pandya, American Journal of Clinical Dermatology; 113 studies, 6,897 participants) concluded that chemical peels and laser and light therapies are "equal or inferior to topicals" for melasma, with a higher risk of adverse effects, and a 2022 systematic review (Neagu and colleagues, Journal of Dermatological Treatment) reports that recurrence rates remain high with every melasma treatment.

Our melasma guide covers the concern, and the laser for melasma page covers the laser question specifically.

Acne scars and surgical scars. Scars sit on the 1550 nm list.

What our research does not hold is any Fraxel-specific scar result — no photographed trial, no improvement percentage — so a scar before-and-after in a practice's gallery is that practice's own result, and the checks in the last section below are how to read it.

Our acne scars guide covers scar types and the evidence for each treatment.

Pigment. Age spots and sun spots are the concerns both wavelengths' lists name; freckles are named explicitly on the 1927 nm list, as pigmented lesions.

One caution applies before any pigment treatment, and it is in the warning below.

The record gives no number for how much Fraxel results vary, and we will not invent one.

What it shows is where the variation comes from.

The concern sets the wavelength: melasma, eye-area wrinkles and scars appear only on the 1550 nm list, while age and sun spots appear on both — so two patients photographed "after Fraxel" may not have had the same procedure at all.

The goal sets the count: Solta ties the number of treatments to individual needs and treatment goals, from one to as many as five.

And healing sets the clock: Solta puts peeling on days 3–4 and its example patient's redness clearing at about day 15 — one patient's course, not a schedule.

The variable you control is sun.

Solta advises SPF 30+ and no direct sun for at least 3 months after the last treatment, and the American Academy of Dermatology notes age spots can return without sun protection.

None of this predicts what your skin will do, and nothing on this page is a promise — which is why the photo checks below matter more than any single gallery.

Advertising rules give you a baseline.

Under the FTC's Endorsement Guides (16 CFR 255.2), a result shown in an ad is read as representative of what consumers will generally achieve — and if it is not, the ad must clearly and conspicuously disclose the generally expected results, with the FTC adding that disclaimers like "results not typical" are generally insufficient on their own.

A gallery of standout cases with no expected-results disclosure is exactly the pattern that rule addresses.

Then read each photo like a document, for four things: how many treatments the patient had, how long after treatment the photo was taken, the lighting, and whether the photos are unretouched.

Manufacturer galleries model the practice — Solta's captions read "Unretouched photos. Actual patient. Individual results may vary." Ask which device produced the photos, too: "Fraxel Dual" names the earlier cleared model of the laser and the current device is the FTX, and the two share the same 1550/1927 wavelengths — the settings behind a photo are still a fair question.

The privacy layer tells you how the gallery got there.

Under HIPAA, full-face photographs are identifiers, so before-and-after photos taken by a covered provider are protected health information, and a covered entity must obtain a patient's written authorization before using identifiable photos in marketing.

Whether a given med spa is a HIPAA covered entity depends on whether it conducts standard electronic transactions such as insurance billing, and state privacy laws can still apply where HIPAA does not — a practice that can explain how its gallery was consented is showing you something no single photo can.

No gallery shows what your skin will do; the closest honest equivalent of a before and after for you is a written plan — concern, wavelength, session count, photographed milestones — from the provider who examined your skin.